Microdialysis in Neurointensive Care
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2145-2152
Author(s):
Urban Ungerstedt and Elham Rostami
The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2239-2248
Author(s):
K. Burgyone, K. Aduri, J. Ananth and S. Parameswaran
Targeting MAPK Signalling: Prometheus Fire or Pandoras Box?
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
1885-1905
Author(s):
Simone Boldt and Walter Kolch
Genetic Studies in Relation to Kuru: An Overview
Journal:
Current Molecular Medicine
Volume:
4
Page:
375-384
Author(s):
L. G. Goldfarb, L. Cervenakova and D. C. Gajdusek
Deubiquitinating Enzymes: Their Functions and Substrate Specificity
Journal:
Current Protein & Peptide Science
Volume:
5
Page:
191-200
Author(s):
Tatiana A. Soboleva and Rohan T. Baker
Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
4
Page:
119-137
Author(s):
Jaime M. Monti
Treatment of Inflammatory and Paraproteinemic Neuropathies
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
141-148
Author(s):
Salvatore Monaco, Emanuela Turri, Gianluigi Zanusso and Barbara Maistrello
Acetylcholinesterase Inhibition in Alzheimers Disease
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
231-251
Author(s):
Bernd Ibach and Ekkehard Haen
Neuropharmacology of Cannabinoid System: From Basic Science to Clinical Applications
Journal:
Current Neuropharmacology
Volume:
2
Page:
1-7
Author(s):
F. R. Buttarelli, F. R. Patacchioli, G. Palladini, E. Brunetti and F. E. Pontieri
Cannabinoid Signaling in Glial Cells in Health and Disease
Journal:
Current Neuropharmacology
Volume:
2
Page:
115-124
Author(s):
Anke Witting and Nephi Stella